Macle Laurent, Jaïs Pierre, Weerasooriya Rukshen, Hocini Mélèze, Shah Dipen C, Choi Kee-Joon, Scavée Christophe, Raybaud Florence, Clémenty Jacques, Haïssaguerre Michel
Hôpital Cardiologique du Haut-Lévêque, Bordeaux-Pessac, France.
J Cardiovasc Electrophysiol. 2002 Nov;13(11):1067-73. doi: 10.1046/j.1540-8167.2002.01067.x.
Catheter ablation of pulmonary veins (PV) for treatment of atrial fibrillation (AF) is limited by the disparate requirements of sufficient energy delivery to achieve PV isolation while avoiding PV stenosis. The aim of the present study was to evaluate the safety and efficacy of using an irrigated-tip catheter for systematic isolation of PV.
The study population consisted of 136 consecutive patients (109 men, mean age 52 +/- 10 years) with symptomatic, drug-refractory paroxysmal (122) or persistent (14) AF. Cavotricuspid isthmus ablation and systematic radiofrequency isolation of all four PVs (guided by a circumferential mapping catheter) was performed in all patients with a protocol using an irrigated-tip catheter. PV diameter was assessed by selective angiography. The electrophysiologic endpoint of PV isolation was achieved in 100% of patients. Bidirectional cavotricuspid isthmus block was achieved in 99% of patients. Moderate PV stenosis (50% narrowing) was observed in one patient (0.7%) without clinical consequence. No other complications were observed. Reablation procedures were required in 67 patients (49%). After a mean follow-up of 8.8 +/- 5.3 months, 81% of patients were free of AF clinical recurrence, including 66% not taking any antiarrhythmic drugs.
Systematic radiofrequency ablation of PV using an irrigated-tip catheter in patients with atrial fibrillation allows complete isolation of all four PVs with a very low incidence of stenosis.
用于治疗心房颤动(AF)的肺静脉(PV)导管消融术受到实现PV隔离所需足够能量传递的不同要求的限制,同时要避免PV狭窄。本研究的目的是评估使用灌注式导管对PV进行系统性隔离的安全性和有效性。
研究人群包括136例连续的有症状、药物难治性阵发性(122例)或持续性(14例)AF患者(109例男性,平均年龄52±10岁)。所有患者均采用灌注式导管,按照方案进行三尖瓣峡部消融和所有四个PV的系统性射频隔离(由环状标测导管引导)。通过选择性血管造影评估PV直径。100%的患者达到了PV隔离的电生理终点。99%的患者实现了双向三尖瓣峡部阻滞。1例患者(0.7%)出现中度PV狭窄(狭窄50%),但无临床后果。未观察到其他并发症。67例患者(49%)需要再次消融。平均随访8.8±5.3个月后,81%的患者无AF临床复发,其中66%未服用任何抗心律失常药物。
在心房颤动患者中使用灌注式导管对PV进行系统性射频消融可实现所有四个PV的完全隔离,且狭窄发生率极低。